Want to join the conversation?
Marc Goodman of UBS asks about gross margins in the generics business. $ENDP said the gross margins held up right in line with expectations. The company set full-year guidance of generics GM in the low 50s and this was the level achieved in 2Q16. The outlook remains consistent for the full year.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th